Αποτελέσματα Αναζήτησης
The integrative recommendations for BRCA testing presented here aim to (1) identify indi- viduals who may benefit from genetic counselling and risk-reducing strategies; (2) update germline and tumour-testing indications for PARPi-approved therapies; (3) provide testing
3 Οκτ 2018 · Article Guidance. This Billing and Coding Article provides billing and coding guidance for Local Coverage Determination (LCD) L36499, BRCA1 and BRCA2 Genetic Testing. Please refer to the LCD for reasonable and necessary requirements. Coding Guidelines.
Variant classification. Reporting test results. Classification and clinical interpretation of genetic variants is intricate and complex. This section describes best practice in reporting the results of BRCA tests and describes how an oncologist can interpret a report from the diagnostics laboratory.
Positive BRCA2 gene. Publication Date: September 2018. ICD 10 AM Edition: Tenth edition. Query Number: 3393. We are trying to find the best way to code for a positive BRCA for either a patient who has a past history of breast cancer or a patient who has a family history of breast cancer.
This list is intended to assist ordering physicians in providing ICD-10 Diagnosis Codes as required by Medicare and other Insurers. It includes the most commonly found out-patient diagnoses (generally without complications), but is not complete.
This list was compiled from the ICD-10-CM 2015 AMA manual. A current ICD-10-CM book should be used as a complete reference. The ultimate responsibility for correct coding belongs to the ordering physician. Sonora Quest Laboratories, the associated logo and marks are the registered trademarks of Sonora Quest Laboratories.
Patients are assigned to categories based upon their pre-test probability of having a BRCA mutation, with a less than 10 % probability considered as low-risk, a 10 to 25 % probability considered as moderate risk, and a greater than 25 % probability being considered as high-risk (USPSTF, 2005).
